Today's interviewee, Professor Chris Snyder, is a Non-Resident Senior Fellow at the Institute for Progress (IFP). He teaches economics at Dartmouth College, where he specializes in industrial organization and microeconomic theory. He is also a research associate at the NBER, treasurer of the Industrial Organization Society, and a faculty director for the University of Chicago's Market Shaping Accelerator.
Chris played a pivotal role in the advance market commitment, or “AMC,” for the pneumococcal vaccine, which saved close to a million lives.
What you’ll learn:
How did the U.S. and Russia end up in the same funding coalition? Why didn’t we design an AMC for malaria? How do you place a market value on future innovations? Why would cancer and Alzheimer’s be poor candidates for an AMC?
Subscribe at www.statecraft.pub to get one new interview in your inbox each week.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit
www.statecraft.pub
